NovoCure
NVCR
NVCR
271 hedge funds and large institutions have $4.75B invested in NovoCure in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 103 increasing their positions, 82 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
19% less capital invested
Capital invested by funds: $5.83B → $4.75B (-$1.09B)
21% less call options, than puts
Call options by funds: $80.5M | Put options by funds: $102M
Holders
271
Holding in Top 10
6
Calls
$80.5M
Puts
$102M
Top Buyers
| 1 | +$79.1M | |
| 2 | +$21.8M | |
| 3 | +$21.6M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$17.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$14M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$18.3M | |
| 3 | -$18.2M | |
| 4 |
Two Sigma Advisers
New York
|
-$18.2M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$15.6M |